Marta Cascioli
Marta Cascioli has a total of 9 co-authors. Here are the top co-authors by number of shared publications:
- Alessandra Lugaresi
Dipartimento di Scienze Biomediche e Neuromotorie, Università di Bologna, Bologna, Italy
1 shared publication - Alessandra Solari
Unit of Neuroepidemiology, Fondazione IRCCS Istituto Neurologico Carlo Besta, Milan, Italy
1 shared publication - Andrea Giordano
Neurology, Public Health, Disability Unit, Fondazione IRCCS Istituto Neurologico C. Besta, Milan, Italy
1 shared publication - Eugenio Pucci
Azienda Sanitaria Territoriale Fermo, UOC Neurologia, Fermo, Italy
1 shared publication - Laura Servidio
Unit of Neuroepidemiology, Fondazione IRCCS Istituto Neurologico Carlo Besta, 20133 Milan, Italy
1 shared publication - Ludovica De Panfilis
Department of Medical and Surgical Sciences, University of Bologna, Bologna, Italy
1 shared publication
Latest Publications
- Open Access
- 12 January 2022
- Published by MDPI AG in International Journal of Environmental Research and Public Health
- Vol. 19 (2) , 803
Advance Care Planning in Neurodegenerative Disorders: A Scoping Review
Advance care planning (ACP) is increasingly acknowledged as a key step to enable patients to define their goals/preferences for future medical care, together with their carers and health professionals. We aimed to map the evidence on ACP in neurodegenerative disorders. We conducted a scoping review by searching PubMed (inception-December 28, 2020) in addition to trial, review, and dissertation registers. From 9367 records, we included 53 studies, mostly conducted in Europe (45%) and US-Canada (41%), within the last five years. Twenty-six percent of studies were qualitative, followed by observational (21%), reviews (19%), randomized controlled trials (RCTs, 19%), quasi-experimental (11%), and mixed-methods (4%). Two-thirds of studies addressed dementia, followed by amyotrophic lateral sclerosis (13%), and brain tumors (9%). The RCT interventions (all in dementia) consisted of educational programs, facilitated discussions, or videos for patients and/or carers. In conclusion, more research is needed to investigate barriers and facilitators of ACP uptake, as well as to develop/test interventions in almost all the neurodegenerative disorders. A common set of outcome measures targeting each discrete ACP behavior, and validated across the different diseases and cultures is also needed.
- 12 January 2022
- Published by MDPI AG in International Journal of Environmental Research and Public Health
- Vol. 19 (2) , 803
Open AccessAdvance Care Planning in Neurodegenerative Disorders: A Scoping Review
Advance care planning (ACP) is increasingly acknowledged as a key step to enable patients to define their goals/preferences for future medical care, together with their carers and health professionals. We aimed to map the evidence on ACP in neurodegenerative disorders. We conducted a scoping review by searching PubMed (inception-December 28, 2020) in addition to trial, review, and dissertation registers. From 9367 records, we included 53 studies, mostly conducted in Europe (45%) and US-Canada (41%), within the last five years. Twenty-six percent of studies were qualitative, followed by observational (21%), reviews (19%), randomized controlled trials (RCTs, 19%), quasi-experimental (11%), and mixed-methods (4%). Two-thirds of studies addressed dementia, followed by amyotrophic lateral sclerosis (13%), and brain tumors (9%). The RCT interventions (all in dementia) consisted of educational programs, facilitated discussions, or videos for patients and/or carers. In conclusion, more research is needed to investigate barriers and facilitators of ACP uptake, as well as to develop/test interventions in almost all the neurodegenerative disorders. A common set of outcome measures targeting each discrete ACP behavior, and validated across the different diseases and cultures is also needed.